A fast-growing, high-grade tumor located in the cerebellum, it is the most common malignant brain tumor in children.
Location
Cerebellum
Histological Classification
Embryonal Tumor
Details
Origin: Embryonal cells
Grade: IV
Severity: High
Molecular Marker: WNT, SHH, Group 3, Group 4
Age Range: 3-8 years
Life Expectancy: 5-10 years
Lifespan Impact
Summary
Medulloblastoma is a type of primary brain tumor that originates in the cerebellum, the part of the brain that controls balance and coordination. It is classified as an embryonal tumor, meaning it arises from undeveloped cells. Medulloblastomas are the most common malignant brain tumors in children but can also occur in adults.
Symptoms
The symptoms of medulloblastoma can vary depending on the tumor's size and location but often include:
Headaches, particularly in the morning
Nausea and vomiting
Balance and coordination issues
Dizziness
Changes in vision, such as double vision
Behavior changes
Fatigue or sleepiness
Seizures, though less common
Surgery
Purpose: To remove as much of the tumor as possible.
Modern Approach: Surgical techniques have advanced significantly with the aid of imaging technologies like MRI, allowing for more precise removal with minimal damage to surrounding tissues.
Radiation Therapy
Purpose: To target and kill remaining cancer cells post-surgery.
Modern Approach: Intensity-modulated radiation therapy (IMRT) and proton beam therapy are more precise methods that minimize damage to healthy brain tissue. These methods have been in use since the early 2000s.
Chemotherapy
Purpose: To kill cancer cells or stop them from growing and dividing.
Modern Approach: Various chemotherapy drugs are used, often in combination, including cisplatin, vincristine, and cyclophosphamide. Newer targeted therapies are being explored to reduce side effects.
Immunotherapy
Description: Involves stimulating the patient's immune system to recognize and attack cancer cells.
Current Status: Trials are ongoing to determine the efficacy of immune checkpoint inhibitors and CAR T-cell therapy in treating medulloblastoma.
Molecularly Targeted Therapy
Description: Focuses on specific genetic changes in tumor cells.
Current Status: Several clinical trials are testing drugs that target molecular pathways involved in tumor growth, such as the Hedgehog and Wnt signaling pathways.
Gene Therapy
Description: Attempts to correct or modify genetic defects responsible for cancer development.
Current Status: Still largely experimental with ongoing research to assess its safety and effectiveness.
Side Effects of Treatments
Surgery
Potential side effects include infection, bleeding, and neurological issues, such as speech and motor difficulties, depending on the tumor's location and extent of removal.
Radiation Therapy
Side effects may include fatigue, skin irritation, cognitive changes, and long-term hormonal imbalances, particularly in children.
Chemotherapy
Common side effects include nausea, vomiting, hair loss, increased risk of infection, and potential long-term effects such as fertility issues and secondary cancers.
Timeline and Modernity of Treatments
Surgery: Enhanced surgical techniques have been developed over the past few decades, with significant improvements in imaging and surgical precision since the 1990s.
Radiation Therapy: IMRT and proton therapy have been increasingly used since the early 2000s.
Chemotherapy: Continuous advancements in drug formulations and combinations, with targeted therapies gaining traction since the 2010s.
Experimental Treatments: Immunotherapy and molecularly targeted therapies have been major research focuses since the 2010s, with ongoing developments.
Medulloblastoma treatment continues to evolve with ongoing research aiming to improve survival rates and reduce treatment-related side effects. Despite current challenges, advances in medical science offer hope for more effective and less toxic treatment options in the future.